Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen ; volume:13 ; number:1 ; day:31 ; month:1 ; year:2011 ; pages:1-12 ; date:2.2011
Breast cancer research ; 13, Heft 1 (31.1.2011), 1-12, 2.2011
- Creator
-
Brennan, Donal J.
- Contributor
-
Laursen, Henriette
O'Connor, Darran P.
Borgquist, Signe
Uhlén, Mathias
Gallagher, William M.
Pontén, Fredrik
Millikan, Robert C.
Rydén, Lisa
Jirström, Karin
SpringerLink (Online service)
- DOI
-
10.1186/bcr2820
- URN
-
urn:nbn:de:1111-2016032411476
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brennan, Donal J.
- Laursen, Henriette
- O'Connor, Darran P.
- Borgquist, Signe
- Uhlén, Mathias
- Gallagher, William M.
- Pontén, Fredrik
- Millikan, Robert C.
- Rydén, Lisa
- Jirström, Karin
- SpringerLink (Online service)
Other Objects (12)
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
HMG-CoA reductase inhibitors
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
HMG
HMG
HMG
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
HMG-CoA reductase inhibitors
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
HMG
HMG
HMG
Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients
HMG-CoA reductase inhibitors
Selection of HMG-coenzyme A reductase inhibitors using multiattribute scoring tool
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
Transcription of the three HMG-CoA reductase genes of Mucor circinelloides
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer
HMG
HMG